Longlive App Ltd Secures Pre Seed Funding for AI Driven Senior Health Platform

Longlive App Ltd, a London based health technology startup focusing on senior wellness and chronic condition management, has confirmed a pre seed funding round of £37k. The investment, which was finalised through an allotment in late 2025 and recently formalised in March 2026 filings, gives the company an estimated post money valuation of £1.1 million.

Founded in June 2021, Longlive App Ltd has spent its initial years in the research and development phase. The company aims to address the growing global challenge of an ageing population and the associated rise in chronic health conditions. Its primary product offering consists of a dedicated mobile application paired with a proprietary smartwatch, designed specifically for older adults.

The core problem Longlive seeks to solve is the lack of accessible, proactive health monitoring tools for the elderly. While the consumer wearable market is saturated with fitness trackers for younger demographics, these devices often fail to provide the clinical depth or user interface required by seniors managing complex health needs. Longlive uses AI driven insights and personalised coaching to help users track vital signs, physical activity, and medication adherence. By identifying early warning signs and patterns, the platform aims to shift geriatric care from a reactive model to a preventative one.

The financial details of the round indicate a lean, targeted approach to early stage growth. The £37,300 injection is a modest pre seed sum, likely intended to support the refinement of the company's AI algorithms or the expansion of its pilot testing programmes. At a valuation of £1.1 million, the company sits at a standard entry point for London based software and hardware hybrids in the health technology space. While the names of the specific investors involved in this allotment were not disclosed in the immediate filings, the round represents the company's first formal step into external capital markets since its incorporation in 2021.

The London tech ecosystem remains a primary hub for such innovations. Longlive operates within a cluster of startups that are increasingly focused on AgeTech, a subsector of HealthTech that is seeing significant growth as healthcare providers look for digital solutions to alleviate the pressure on the NHS and private care facilities. Recent data from the UK funding landscape suggests that while large scale growth rounds have seen some volatility, early stage pre seed and seed activity remains consistent, particularly for companies addressing clear social and demographic needs.

In the context of the UK HealthTech sector, Longlive is positioned in a niche but high growth area. The integration of wearable hardware with artificial intelligence is a high barrier to entry field, requiring both technical precision and a deep understanding of senior user experience.